合成路线1
该中间体在本合成路线中的序号:
(B) The reaction of 2-chloro-3,5-dinitrobenzoic acid (I) with thionil chloride, followed by treatment with diethyl ethoxymagnesium malonate gives diethyl 2-chloro-3,5-dinitrobenzoylmalonate (II), which is hydrolyzed and decarboxylated in hot sulfuric acid/propionic acid yielding 2-chloro-3,5-dinitroacetophenone (III). Reaction of (III) with thioglycolic acid by means of NaHCO3 in refluxing isopropanol gives the thioacetic acid compound (IV), which is cyclized in refluxing propionic acid yielding 3-methyl-5,7-dinitrobenzothiophene (V). Partial selective reduction of one of the nitro groups in (V) by means of ammonium sulfide in ethanol leads to 7-amino-3-methyl-5-nitrobenzothiophene (VI), which is diazotied by treatment with NaNO2 in hydrochloric acid. The following reaction with diethylamine in alkaline solution gives the triazene derivative (VII), which is finally fluorinated by reaction with anhydrous HF yielding 7-fluoro-3-methyl-5-nitrobenzothiophene (VIII). Catalytical reduction of (VIII) yields 5-amino-7-fluoro-3-methylbenzothiophene (IX), which is converted to 5-hydrazino-7-fluoro-3-methylbenzothiophene (X) by diazotation and subsequent reduction by means of stannous chloride in hydrochloric acid. The reaction of (X) with N-ethyl-4-piperidone (XI) in refluxing isopropanol gives the corresponding hydrazone, which is cyclized in refluxing isopropanol/HCl yiellding tiflucarbine base. Finally, this compound is converted to the lactate by means of lactic acid in acetone.
【1】
Urda, E.; Sahi, J.; Wen, Y.-H.; et al.; IXth Intl Symp Med Chem (September 14-18, Berlin) 1986, 30, 9, 977.
|
【2】
Schollnhammer, G.; Seidel, P.-R. (Troponwerke GmbH & Co KG); 7,8,9,10-tetrahydrothieno[3,2-e]pyrido[4,3-b]indole, a process for their preparation and medicaments containing them. EP 0120439; US 4816461 .
|
【3】
Glaser, T.; Seidel, P.-R.; Tiflucarbine. Drugs Fut 1987, 12, 6, 562.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
18524 |
2-sulfanylacetic acid
|
68-11-1 |
C2H4O2S |
详情 | 详情
|
(A) |
28858 |
diethyl ethoxymagnesiummalonate
|
|
C9H16MgO5 |
详情 |
详情
|
(I) |
28857 |
2-chloro-3,5-dinitrobenzoic acid
|
2497-91-8 |
C7H3ClN2O6 |
详情 | 详情
|
(II) |
28859 |
diethyl 2-(2-chloro-3,5-dinitrobenzoyl)malonate
|
|
C14H13ClN2O9 |
详情 |
详情
|
(III) |
28860 |
1-(2-chloro-3,5-dinitrophenyl)-1-ethanone
|
|
C8H5ClN2O5 |
详情 |
详情
|
(IV) |
28861 |
2-[(2-acetyl-4,6-dinitro-2,4-cyclohexadien-1-yl)sulfanyl]acetic acid
|
|
C10H10N2O7S |
详情 |
详情
|
(V) |
28862 |
3-methyl-5,7-dinitro-1-benzothiophene
|
|
C9H6N2O4S |
详情 |
详情
|
(VI) |
28863 |
3-methyl-5-nitro-1-benzothiophen-7-ylamine
|
|
C9H8N2O2S |
详情 |
详情
|
(VII) |
28864 |
(E)-3,3-dimethyl-1-(3-methyl-5-nitro-1-benzothiophen-7-yl)-1-triazene
|
|
C11H12N4O2S |
详情 |
详情
|
(VIII) |
28865 |
7-fluoro-3-methyl-5-nitro-1-benzothiophene
|
|
C9H6FNO2S |
详情 |
详情
|
(IX) |
28866 |
7-fluoro-3-methyl-1-benzothiophen-5-amine
|
|
C9H8FNS |
详情 |
详情
|
(X) |
28867 |
1-(7-fluoro-3-methyl-1-benzothiophen-5-yl)hydrazine
|
|
C9H9FN2S |
详情 |
详情
|
(XI) |
10919 |
1-Methyl-4-piperidone; 1-Methyltetrahydro-4(1H)-pyridinone; N-Methyl-4-piperidone;1-methylpiperidin-4-one |
1445-73-4 |
C6H11NO |
详情 | 详情
|
(XII) |
28869 |
2-hydroxypropionic acid; Lactic acid
|
50-21-5 |
C3H6O3 |
详情 | 详情
|
合成路线2
该中间体在本合成路线中的序号:
(B) Erdosteine (III) can be obtained in a two-step synthesis starting from homocysteine thiolactone (I). (I) is acylated in chloroform with chloroacetyl chloride (A) to the amide (II). Subsequent reaction with thioglycolic acid (B) gives rise to (III).
【1】
Gobetti, M.; Pedrazzoli, A.; Bradamante, S.; DL-S-[2-[N-3-(2-Oxotetrahydrothienyl)acetamido]]-thioglycolic acid: A novel mucolytic agent of the class of homocysteine thiolactone derivatives. Farm Sci Ed 1986, 41, 1, 69-79.
|
【2】
Fregnan, G.B.; Pappalardo, M.; ERDOSTEINE < Rec INN >. Drugs Fut 1990, 15, 9, 887.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
11296 |
2-Chloroacetyl chloride; Chloroacetic chloride
|
79-04-9 |
C2H2Cl2O |
详情 | 详情
|
(B) |
18524 |
2-sulfanylacetic acid
|
68-11-1 |
C2H4O2S |
详情 | 详情
|
(I) |
22495 |
3-aminodihydro-2(3H)-thiophenone
|
10593-85-8 |
C4H7NOS |
详情 | 详情
|
(II) |
31177 |
2-chloro-N-(2-oxotetrahydro-3-thiophenyl)acetamide
|
84611-22-3 |
C6H8ClNO2S |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(V) The protected ligand (IV) was also prepared by a related method. The acylation of thioglycolic acid (V) with benzoyl chloride (VI) under Schotten-Baumann conditions afforded S-benzoyl thioglycolic acid (VII). After activation of (VII) as the corresponding succinimidyl ester (VIII) with N-hydroxysuccinimide and DCC, coupling with triglycine (I) furnished compound (IV).
【1】
Grummon, G.; et al.; Synthesis, characterization and crystal structures of technetium(V)-oxo complexes useful in nuclear medicine. 1. Complexes of mercaptoacetylglycylglycylglycine (MAG3) and its methyl ester derivative (MAG3OMe). Inorg Chem 1995, 34, 7, 1764. |
【2】
Brandau, W.; et al.; Technetium-99m labeled renal function and imaging agents. 3. Synthesis of Tc-99m-MAG3 and biodistribution of by-products. Int J Radiat Appl Instrum Part A - Appl Radiat Isotop 1988, 39, 2, 121.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
56518 |
2-({2-[(2-aminoacetyl)amino]acetyl}amino)acetic acid
|
|
C6H11N3O4 |
详情 |
详情
|
(IV) |
56520 |
1,4,7,10-tetraoxo-1-phenyl-2-thia-5,8,11-triazatridecan-13-oic acid
|
|
C15H17N3O6S |
详情 |
详情
|
(V) |
18524 |
2-sulfanylacetic acid
|
68-11-1 |
C2H4O2S |
详情 | 详情
|
(VI) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(VII) |
56522 |
2-(benzoylsulfanyl)acetic acid
|
|
C9H8O3S |
详情 |
详情
|
(VIII) |
56523 |
S-{2-[(2,5-dioxo-1-pyrrolidinyl)oxy]-2-oxoethyl} benzenecarbothioate
|
|
C13H11NO5S |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(V) Other S-protecting groups for mercaptoacetyl triglycine have been reported. The S-benzyl derivative (X) was prepared by condensation of triglycine (I) with (benzylthio)acetyl chloride (IX). Alternatively, the S-benzamidomethyl compound (XII) was prepared as follows. Thioglycolic acid (V) was condensed with benzamidomethanol under acidic conditions to give S-(benzamidomethyl)thioglycolic acid (XI), which was then coupled to triglycine (I) using DCC/HOBt. Deprotection in the presence of 99Tc pertechnetate under the same conditions as above furnished the title Tc complex.
【1】
Okarvi, S.M.; et al.; Comparison of the labelling characteristics of mercaptoacetyltriglycine (MAG3) with different S-protective groups. J Label Compd Radiopharm 1997, 39, 10, 853.
|
【2】
Bormans, G.; et al.; Investigation of the labelling characteristics of 99mTc-mercaptoacetyltriglycine. Nucl Med Biol 1995, 22, 3, 339.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
56518 |
2-({2-[(2-aminoacetyl)amino]acetyl}amino)acetic acid
|
|
C6H11N3O4 |
详情 |
详情
|
(V) |
18524 |
2-sulfanylacetic acid
|
68-11-1 |
C2H4O2S |
详情 | 详情
|
(IX) |
56524 |
2-(benzylsulfanyl)acetyl chloride
|
|
C9H9ClOS |
详情 |
详情
|
(X) |
56525 |
4,7,10-trioxo-1-phenyl-2-thia-5,8,11-triazatridecan-13-oic acid
|
|
C15H19N3O5S |
详情 |
详情
|
(XI) |
56526 |
2-{[(benzoylamino)methyl]sulfanyl}acetic acid
|
|
C10H11NO3S |
详情 |
详情
|
(XII) |
56527 |
1,6,9,12-tetraoxo-1-phenyl-4-thia-2,7,10,13-tetraazapentadecan-15-oic acid
|
|
C16H20N4O6S |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(XXV) The acylation of 2-butene-1,4-diol (XXII) with butyryl chloride and DMAP in pyridine gives the dibutyrate (XXIII), which is ozonolyzed with O3 in dichloromethane yielding the aldehyde (XXIV). The cyclization of (XXIV) with mercaptoacetic acid (XXV) in refluxing toluene affords 2-(butyryloxymethyl)-1,3-oxathiolane-5-one (XXVI), which is reduced with lithium tri-tert-butoxyaluminum hydride and acetylated with acetic anhydride in THF to give 5-acetoxy-2-(butyryloxymethyl)-1,3-oxathiolane (XXVII). The condensation of (XXVII) with disilylated 5-fluorocytosine (XV) (obtained from cytosine (XVI) as described) by means of SnCl4 in dichloromethane yields the racemic butyryl nucleoside rac-(cis)-(XXVIII). The biological resolution of this racemic mixture has been performed by digestion with the enzyme pig liver esterase (PLE-A) providing a mixture of unreacted (-)-(cis)-(2R,5S)-(XXVIII) butyrate and hydrolyzed (+)-(cis)-(2S,5R)-(XXIX) that are separated by fractional extraction. The desired (-)-(cis)-(2R,5S)-enantiomer is finally hydrolyzed to the target compound with NaOMe in methanol.
The biological resolution of rac-(cis)-(XXVIII) can also be performed with the enzyme Amano PS-800 yielding a mixture of unreacted (+)-(cis)-(2S,5R)-(XXVIII) butyrate and the desired (-)-(cis)-(2R,5S) target nuceloside that are separated by fractional extraction.
【1】
Liotta, D.C.; Schinazi, R.F.; Choi, W.-B. (Emory University); Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1, 3-oxathiolane. EP 0984013; JP 1994508605; JP 1998147586; WO 9214743 .
|
【2】
Hoong, L.K.; et al.; Enzyme-mediated enantioselective preparation of pure enantiomers of the antiviral agent 2', 3'-dideoxy-5-fluoro-3'-thiacytidine (FTC) and related compounds. J Org Chem 1992, 57, 21, 5563.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(rac)-(XXVIII) |
36970 |
(rac)-[(2R,5S)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl butyrate
|
|
C12H16FN3O4S |
详情 |
详情
|
(+)-(XXVIII) |
36971 |
[(2S,5R)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl butyrate
|
|
C12H16FN3O4S |
详情 |
详情
|
(-)-cis-(XXVIII) |
36972 |
(-)-cis-[(2R,5S)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl butyrate
|
|
C12H16FN3O4S |
详情 |
详情
|
(XV) |
36959 |
5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine
|
|
C10H20FN3OSi2 |
详情 |
详情
|
(XVI) |
16747 |
4-amino-5-fluoro-2(1H)-pyrimidinone; 5-fluorocytosine |
2022-85-7 |
C4H4FN3O |
详情 | 详情
|
(XXII) |
36965 |
(Z)-2-butene-1,4-diol
|
6117-80-2 |
C4H8O2 |
详情 | 详情
|
(XXIII) |
36966 |
(Z)-4-(butyryloxy)-2-butenyl butyrate
|
|
C12H20O4 |
详情 |
详情
|
(XXIV) |
36967 |
2-oxoethyl butyrate
|
|
C6H10O3 |
详情 |
详情
|
(XXV) |
18524 |
2-sulfanylacetic acid
|
68-11-1 |
C2H4O2S |
详情 | 详情
|
(XXVI) |
36968 |
(5-oxo-1,3-oxathiolan-2-yl)methyl butyrate
|
|
C8H12O4S |
详情 |
详情
|
(XXVII) |
36969 |
[5-(acetoxy)-1,3-oxathiolan-2-yl]methyl butyrate
|
|
C10H16O5S |
详情 |
详情
|
(XXIX) |
36963 |
4-amino-5-fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone
|
|
C8H10FN3O3S |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(IV) A new process for the preparation of emtricitabine has been described: The esterification of 2-butene-1,4-diol (I) with butyryl chloride and DMAP in pyridine gives the diester (II), which by ozonolysis with O3 in methanol provides the hemiacetal (III). Cyclization of (III) with 2-mercaptoacetic acid in refluxing toluene affords racemic 2-(butyryloxymethyl)-1,3-oxathiolan-5-one (V), which is submitted to optical resolution to afford the (R)-enantiomer (VI). The reduction of (VI) with Li(t-BuO)3AlH, followed by acetylation with acetic anhydride gives 5-(acetoxy)-2(R)-(butyryloxy)-1,3-oxathiolane (VII), which by treatment with HCl in dichloroethane is converted into 2(R)-(butyryloxy)-5-chloro-1,3-oxathiolane (VIII). Condensation of (VIII) with 5-fluoro-bis(trimethylsilyl)cytosine (IX) obtained by silylation of cytosine (X) with HMDS by means of NaHCO3 in dichloroethane gives a diastereomeric mixture of the butyrate nucleosides (XI), which is hydrolyzed with butylamine in methanol yielding the corresponding diastereomeric mixture of the (2R,5S)-isomer, emtricitabine, and the (2R,5R)-isomer (XII). This mixture is separated by crystallization of the corresponding hydrochlorides obtained by treatment with HCl in methanol/dioxane.
【1】
Almond, M.; Painter, G.R.; Liotta, D.C.; Cleary, D.; Soria, J. (Emory University; Triangle Pharmaceuticals, Inc.); Method of manufacture of 1,3-oxathiolane nucleosides. WO 0009494 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
36965 |
(Z)-2-butene-1,4-diol
|
6117-80-2 |
C4H8O2 |
详情 | 详情
|
(II) |
36966 |
(Z)-4-(butyryloxy)-2-butenyl butyrate
|
|
C12H20O4 |
详情 |
详情
|
(III) |
39681 |
2-hydroxy-2-methoxyethyl butyrate
|
|
C7H14O4 |
详情 |
详情
|
(IV) |
18524 |
2-sulfanylacetic acid
|
68-11-1 |
C2H4O2S |
详情 | 详情
|
(V) |
36968 |
(5-oxo-1,3-oxathiolan-2-yl)methyl butyrate
|
|
C8H12O4S |
详情 |
详情
|
(VI) |
39682 |
[(2R)-5-oxo-1,3-oxathiolan-2-yl]methyl butyrate
|
|
C8H12O4S |
详情 |
详情
|
(VII) |
39683 |
[(2R)-5-(acetoxy)-1,3-oxathiolan-2-yl]methyl butyrate
|
|
C10H16O5S |
详情 |
详情
|
(VIII) |
39685 |
[(2R)-5-chloro-1,3-oxathiolan-2-yl]methyl butyrate
|
|
C8H13ClO3S |
详情 |
详情
|
(IX) |
36959 |
5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine
|
|
C10H20FN3OSi2 |
详情 |
详情
|
(X) |
16747 |
4-amino-5-fluoro-2(1H)-pyrimidinone; 5-fluorocytosine |
2022-85-7 |
C4H4FN3O |
详情 | 详情
|
(XI) |
36970 |
(rac)-[(2R,5S)-5-[4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl]-1,3-oxathiolan-2-yl]methyl butyrate
|
|
C12H16FN3O4S |
详情 |
详情
|
(XII) |
36984 |
benzyl 6-oxo-5,6,7,8-tetrahydro-2-naphthalenylcarbamate
|
|
C18H17NO3 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(IV) Aldehyde (I) was condensed with 3-aminopropanol (II) in refluxing benzene using a Dean-Stark trap to give imine (III) which, without purification, was in turn condensed with a-mercaptoacetic acid (IV) to afford thiazolidinone (V). Treatment of alcohol (V) with PBr3 gave bromide (VI). Then, reaction of (VI) with amine (VII) in the presence of K2CO3 in refluxing acetone produced the target compound.
【1】
Kato, T.; Ozaki, T.; Tamura, K.; Suzuki, Y.; Akima, M.; Ohi, N.; Novel calcium antagonists with both calcium overload inhibition and antioxidant activity. 1. 2-(3,5-Di-tert-butyl-4-hydroxyphenyl)-3-(aminopropyl)thiazolidinones. J Med Chem 1998, 41, 22, 4309. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
14875 |
3,5-Bis(1,1-dimethylethyl)-4-hydroxybenzaldehyde; 3,5-di(tert-butyl)-4-hydroxybenzaldehyde; 3,5-Di-tert-butyl-4-hydroxybenzaldehyde
|
1620-98-0 |
C15H22O2 |
详情 | 详情
|
(II) |
18522 |
3-amino-1-propanol
|
156-87-6 |
C3H9NO |
详情 | 详情
|
(III) |
18523 |
2,6-di(tert-butyl)-4-[[(3-hydroxypropyl)imino]methyl]phenol
|
|
C18H29NO2 |
详情 |
详情
|
(IV) |
18524 |
2-sulfanylacetic acid
|
68-11-1 |
C2H4O2S |
详情 | 详情
|
(V) |
18525 |
2-[3,5-di(tert-butyl)-4-hydroxyphenyl]-3-(3-hydroxypropyl)-1,3-thiazolidin-4-one
|
|
C20H31NO3S |
详情 |
详情
|
(VI) |
18526 |
3-(3-bromopropyl)-2-[3,5-di(tert-butyl)-4-hydroxyphenyl]-1,3-thiazolidin-4-one
|
|
C20H30BrNO2S |
详情 |
详情
|
(VIII) |
12561 |
2-(1,3-Benzodioxol-5-yloxy)-N-methyl-1-ethanamine; N-[2-(1,3-Benzodioxol-5-yloxy)ethyl]-N-methylamine
|
|
C10H13NO3 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(VI) Title compound has been prepared by several related ways. Alkylation of methyl acetoacetate (I) with n-heptyl bromide (II) in the presence of NaOMe in refluxing MeOH yielded (III), which was brominated in CHCl3 at 0 C to give (IV). Subsequent reaction with triphenylmethyl mercaptan (V) and tetrabutyl ammonium hydroxide in toluene at r.t. provided (XI).
Alternatively, beta-ketoester (XI) was prepared from a-mercaptoacetic acid (VI). Thus, protection as the S-trityl compound (VIII) by treatment with triphenylcarbinol (VII) and TFA, followed by condensation with N,O-dimethyl hydroxylamine in the presence of EDC and HOBt afforded N-methoxyamide (IX). Then, Claisen condensation with methyl nonanoate (X) using LDA as the base in THF at -78 C provided ketoester (XI). In order to avoid b-ketoacid decarboxylation, ketone (XI) was reduced to alcohol (XV) with NaBH4 in MeOH at 0 C.
This hydroxyester was also prepared by a related route, consisting of protection of methyl mercaptoacetate (XII) as the S-trityl compound (XIII), followed by reduction to aldehyde (XIV) with DIBAL-H and condensation with methyl nonanoate (X). Saponification of methyl ester (XV) with KOH yielded hydroxyacid (XVI). Subsequent coupling with tert-butylglycine amide (XVII) using EDC and HOBt as the condensing agents produced amide (XVIII). Ketoamide (XX) was then obtained by oxidation with Dess-Martin periodinane (XIX). Finally, deprotection of the S-trityl group was effected by trifluoroacetic acid treatment under reducing conditions with triethyl silane to provide the target compound.
【1】
Campbell, D.A.; Xiao, X.Y.; Harris, D.; Ida, S.; Mortezaei, R.; Ngu, K.; Shi, L.; Tien, D.; Wang, Y.; Navre, M.; Patel, D.V.; Sharr, M.A.; DiJoseph, J.F.; Killar, L.M.; Leone, C.L.; Levin, J.I.; Skotnicki, J.S.; Malonyl alpha-mercaptoketones and alpha-mercaptoalcohols, a new class of matrix metalloproteinase inhibitors. Bioorg Med Chem Lett 1998, 8, 10, 1157. |
【2】
Campbell, D.A.; Patel, D.V.; Xiao, X.Y. (Affymax Technologies, NV); Novel inhibitors of collagenase-1 and stromelysin-I metalloproteases, pharmaceutical compsns. comprising same and methods of their use. WO 9640204 .
|
【3】
Campbell, D.A.; Patel, D.V.; Xiao, X.Y. (Affymax Technologies, NV); Novel inhibitors of metalloproteases, pharmaceutical compsns. comprising same and methods of their use. WO 9640738 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11791 |
methyl 3-oxobutanoate; Methyl acetoacetate
|
105-45-3 |
C5H8O3 |
详情 | 详情
|
(II) |
18828 |
1-bromoheptane
|
629-04-9 |
C7H15Br |
详情 | 详情
|
(III) |
18829 |
methyl 2-acetylnonanoate
|
|
C12H22O3 |
详情 |
详情
|
(IV) |
18830 |
methyl 2-(2-bromoacetyl)nonanoate
|
|
C12H21BrO3 |
详情 |
详情
|
(V) |
18831 |
tritylhydrosulfide; triphenylmethanethiol
|
3695-77-0 |
C19H16S |
详情 | 详情
|
(VI) |
18524 |
2-sulfanylacetic acid
|
68-11-1 |
C2H4O2S |
详情 | 详情
|
(VII) |
18833 |
Trityl alcohol; triphenylmethanol
|
76-84-6 |
C19H16O |
详情 | 详情
|
(VIII) |
18834 |
2-(tritylsulfanyl)acetic acid
|
|
C21H18O2S |
详情 |
详情
|
(IX) |
18835 |
N-methoxy-N-methyl-2-(tritylsulfanyl)acetamide
|
|
C23H23NO2S |
详情 |
详情
|
(X) |
18836 |
methyl nonanoate
|
1731-84-6 |
C10H20O2 |
详情 | 详情
|
(XI) |
18837 |
methyl 2-[2-(tritylsulfanyl)acetyl]nonanoate
|
|
C31H36O3S |
详情 |
详情
|
(XII) |
18838 |
methyl 2-sulfanylacetate
|
2365-48-2 |
C3H6O2S |
详情 | 详情
|
(XIII) |
18839 |
methyl 2-(tritylsulfanyl)acetate
|
|
C22H20O2S |
详情 |
详情
|
(XIV) |
18840 |
2-(tritylsulfanyl)acetaldehyde
|
|
C21H18OS |
详情 |
详情
|
(XV) |
18841 |
methyl 2-[1-hydroxy-2-(tritylsulfanyl)ethyl]nonanoate
|
|
C31H38O3S |
详情 |
详情
|
(XVI) |
18842 |
2-[1-hydroxy-2-(tritylsulfanyl)ethyl]nonanoic acid
|
|
C30H36O3S |
详情 |
详情
|
(XVII) |
18843 |
(2S)-2-amino-N,3,3-trimethylbutanamide
|
89226-12-0 |
C7H16N2O |
详情 | 详情
|
(XVIII) |
18844 |
N-[(1S)-2,2-dimethyl-1-[(methylamino)carbonyl]propyl]-2-[1-hydroxy-2-(tritylsulfanyl)ethyl]nonanamide
|
|
C37H50N2O3S |
详情 |
详情
|
(XIX) |
18845 |
Dess-Martin periodinane; 1,1,1-Triacetoxy-1,2-benziodoxol-3(1H)-one
|
87413-09-0 |
C13H13IO8 |
详情 | 详情
|
(XX) |
18846 |
N-[(1S)-2,2-dimethyl-1-[(methylamino)carbonyl]propyl]-2-[2-(tritylsulfanyl)acetyl]nonanamide
|
|
C37H48N2O3S |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(III) The title diaryl thiazolidinone was synthesized by condensation between 2,6-dichlorobenzaldehyde (I), 2-amino-6-methylpyridine (II) and mercaptoacetic acid (III) in refluxing toluene.
【1】
Barreca, M.L.; et al.; Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents. Bioorg Med Chem Lett 2001, 11, 13, 1793.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
27507 |
2,6-dichlorobenzaldehyde
|
83-38-5 |
C7H4Cl2O |
详情 | 详情
|
(II) |
19678 |
6-methyl-2-pyridinamine; 6-methyl-2-pyridinylamine; 6-amino-2-picoline; 2-Amino-6-methylpyridine
|
1824-81-3 |
C6H8N2 |
详情 | 详情
|
(III) |
18524 |
2-sulfanylacetic acid
|
68-11-1 |
C2H4O2S |
详情 | 详情
|
合成路线10
该中间体在本合成路线中的序号:
(II) The cyclocondensation of N,N'-bis(3,4-dichlorobenzylidene)ethylenediamine (I) with 2-sulfanylacetic acid (II) in refluxing toluene gives a mixture of the meso (R,S)-isomer and the corresponding racemate (R,R)+(S,S), which is easily separated by HPLC on a Chiracel OD column to obtain the target meso (R,S)-isomer.
【1】
Vigorita, M.G.; et al.; Synthesis and antiinflammatory, analgesic activity of 3,-3'-(1,2-ethanediyl)-bis[2-aryl-4-thiazolidinone] chiral compounds, Part 10. Bioorg Med Chem Lett 2001, 11, 21, 2791.
|
【2】
Gabriella, M.; et al.; 3,3'-Bi(1,3-thiazolidin-4-one) system. VIII. 3,3'-(1,2-ethanedyl) derivatives ans corresponding 1,1'-disulfones: Synthesis, stereochemistry and antiinflammatory activity. Farmaco 1997, 52, 1, 43.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
54420 |
(2S)-2-(3,4-dichlorophenyl)-3-{2-[(2S)-2-(3,4-dichlorophenyl)-4-oxo-1,3-thiazolidin-3-yl]ethyl}-1,3-thiazolidin-4-one
|
|
C20H16Cl4N2O2S2 |
详情 |
详情
|
(I) |
54419 |
N-[(Z)-(3,4-dichlorophenyl)methylidene]-N-(2-{[(Z)-(3,4-dichlorophenyl)methylidene]amino}ethyl)amine; N~1~,N~2~-bis[(Z)-(3,4-dichlorophenyl)methylidene]-1,2-ethanediamine
|
|
C16H12Cl4N2 |
详情 |
详情
|
(II) |
18524 |
2-sulfanylacetic acid
|
68-11-1 |
C2H4O2S |
详情 | 详情
|
合成路线11
该中间体在本合成路线中的序号:
(V)
【1】
Liotta DC, Schinazi RF, et al.1993. The preparation of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds as anti-HIV nucleosides. US 5210085 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12234 |
2-Propen-1-ol; Allyl alcohol
|
107-18-6 |
C3H6O |
详情 | 详情
|
(II) |
66313 |
tert-Butylchlorodiphenylsilane;tert-Butyldiphenylchlorosilane;tert-Butyldiphenylsilyl chloride |
58479-61-1 |
C16H19ClSi |
详情 | 详情
|
(III) |
66314 |
(allyloxy)(tert-butyl)diphenylsilane |
|
C19H24OSi |
详情 | 详情
|
(IV) |
44475 |
2-[[tert-butyl(diphenyl)silyl]oxy]acetaldehyde
|
|
C18H22O2Si |
详情 |
详情
|
(V) |
18524 |
2-sulfanylacetic acid
|
68-11-1 |
C2H4O2S |
详情 | 详情
|
(VI) |
66315 |
2-(((tert-butyldiphenylsilyl)oxy)methyl)-1,3-oxathiolan-5-one |
|
C20H24O3SSi |
详情 | 详情
|
(VII) |
55072 |
(2R)-2-({[tert-butyl(diphenyl)silyl]oxy}methyl)-1,3-oxathiolan-4-yl acetate
|
|
C22H28O4SSi |
详情 |
详情
|
(VIII) |
36959 |
5-fluoro-N-(trimethylsilyl)-2-[(trimethylsilyl)oxy]-4-pyrimidinamine; N-[5-fluoro-2-[(trimethylsilyl)oxy]-4-pyrimidinyl]-N-(trimethylsilyl)amine
|
|
C10H20FN3OSi2 |
详情 |
详情
|
(IX) |
66316 |
4-amino-1-((2S,5R)-2-(((tert-butyldiphenylsilyl)oxy)methyl)-1,3-oxathiolan-5-yl)-5-fluoropyrimidin-2(1H)-one |
|
C24H28FN3O3SSi |
详情 | 详情
|